Clinical trial Recruiting at 1 site Observational Ages 18 and up

Evaluating the ALPS Proximal Humerus Plating System for shoulder fractures

Official title: Clinical Outcomes of the ALPS Proximal Humerus Plating System

Run by Vanderbilt University Medical Center · NCT03328650 · Data updated 2026-11-12

This study is testing how well a new shoulder plate works for people with shoulder fractures by looking at their strength, movement, and pain levels after treatment.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment150 (estimated)
SponsorVanderbilt University Medical Center
Academic / other
Locations1 site (Nashville, Tennessee)
StatusRecruiting
StartedAugust 7, 2017
Main results expectedDecember 1, 2031
Study endsDecember 1, 2031
Registry record updatedMay 11, 2026
Trial IDNCT03328650 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults aged 18 and older with a proximal humerus fracture requiring surgical intervention using the A.L.P.S Proximal Humerus Plating System.

Probably not a fit

Patients under 18, those with infections or severe psychiatric disorders, and individuals who do not speak English may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to document the clinical outcomes and performance of the A.L.P.S® Proximal Humerus Plating System in patients with proximal humeral fractures. It involves physical assessments to measure shoulder strength and range of motion, as well as physician evaluations of radiographs. Additionally, patient-reported outcomes regarding pain levels, functional capabilities, and work or leisure restrictions will be collected. The study will also track any revisions, complications, and adverse events associated with the treatment.

Why it matters

Potential benefit: If successful, this study could improve treatment strategies for proximal humeral fractures, leading to better patient outcomes.

How similar studies have gone: While this study focuses on a specific plating system, similar approaches in evaluating surgical interventions for fractures have shown promising results in the past.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients who present with a proximal humerus fracture requiring primary or revision ORIF using A.L.P.S Proximal Humerus Plating System
* Patients who present with a proximal humerus fracture that involves the metaphysis
* 18 years or older

Exclusion Criteria:

* Patients under the age of 18
* Patients who have an infection, sepsis, or osteomyelitis
* Patients who are unwilling to take part in study, have documented psychiatric disorder that limits ability to consent and maintain follow-up, or who may have severe problems maintaining follow-up (e.g. patients who are prisoners, homeless, intellectually changed without adequate family support)
* Patients who do not speak English (do to unavailability of non-English surveys)
* Patients who have known risk factors of pathologic fractures (e.g. bone metastasis)
* Patients who have received treatment for osteoporosis (e.g. bisphosphonate) within the last 5 years or whose treatment lasted longer than 5 years
* Patients who have Type 1 diabetes
* Patients who have other bone disease (e.g. osteogenesis imperfecta, Paget's disease, thyroid disease, Vitamin D deficiency, hyperparathyroidism)
* Patients that have a history of cancer, abnormal serum calcium, or chronic steroid use

Where it's running

  • Vanderbilt Orthopaedics
    Nashville, Tennessee, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.